Dr. Kalfus
InvestorConsulting Medical Director at LifeSci Venture Partners
About
A physician with extensive clinical and medical affairs experience, he was Chief Medical Officer at Thar Pharmaceuticals (acquired by Grunenthal in 2016) and previously VP of Medical Affairs at Lev Pharmaceuticals, where he led clinical development for the HAE therapy Cinryze. He holds an M.D. from Albert Einstein College of Medicine and a B.A. in Biology from Columbia University.
Colleagues at LifeSci Venture Partners
Frequently asked questions
- Who is Dr. Kalfus?
- A physician with extensive clinical and medical affairs experience, he was Chief Medical Officer at Thar Pharmaceuticals (acquired by Grunenthal in 2016) and previously VP of Medical Affairs at Lev Pharmaceuticals, where he led clinical development for the HAE therapy Cinryze. He holds an M.D. from Albert Einstein College of Medicine and a B.A. in Biology from Columbia University.
- Where does Dr. Kalfus work?
- Dr. Kalfus is Consulting Medical Director at LifeSci Venture Partners.